Trials / Recruiting
RecruitingNCT07377591
A Study of HDM2006 in Patients With Advanced Solid Tumor
A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of HDM2006 Monotherapy in Patients With Advanced Solid Tumors
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a first-in-human (FIH) study to evaluate the safety and preliminary efficacy of experimental drug HDM2006 in patients with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HDM2006 | Oral administration within half an hour after a meal, QD |
Timeline
- Start date
- 2024-12-31
- Primary completion
- 2026-09-01
- Completion
- 2027-03-01
- First posted
- 2026-01-30
- Last updated
- 2026-01-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07377591. Inclusion in this directory is not an endorsement.